Page last updated: 2024-11-09

safranine t

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

safranin O : An organic chloride salt having 3,7-diamino-2,8-dimethyl-5-phenylphenazin-5-ium as the counterion. It is commonly used for staining Gram negative bacteria. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2723800
CHEMBL ID5195997
SCHEMBL ID15265
MeSH IDM0053687

Synonyms (84)

Synonym
nsc47719
safranine ts
hidaco safranine
safranine yn
safranine y
ci 50240
nsc-47719
nippon kagaku safranine gk
leather red ht
nippon kagaku safranine t
safranine ok
2,8-dimethylphenosafranine
safranine zh
477-73-6
brilliant safranine br
safranine o
calcozine red y
brilliant safranine g
safranine a
phenazinium,7-diamino-2,8-dimethyl-5-phenyl-, chloride
safranine gf
mitsui safranine t
safranin t
safranine t
safranine j
brilliant safranine gr
tolusafranine
safranine
safranine g
safranine tn
safranine superfine g
safranine th
safranine b
c.i. basic red 2
cerven zasadita 2 [czech]
3,7-diamino-2,8-dimethyl-5-phenylphenazinium chloride
mitsui safranine
einecs 207-518-8
nsc 47719
phenazinium, 3,7-diamino-2,8-dimethyl-5-phenyl-, chloride
ccris 1215
gossypimine
3,7-diamino-2,8-dimethyl-5-phenazinium chloride
hsdb 2723
basic red 2
safranin
c.i. 50240
safranin o
safranin o, certified by the biological stain commission
safranin o, dye content >=85 %
S-0700
AKOS000283004
cotton red
FT-0690012
3,7-diamino-2,8-dimethyl-5-phenylphenazin-5-ium chloride
xtx0yxu2hv ,
phenazinium, 3,7-diamino-2,8-dimethyl-5-phenyl-, chloride (1:1)
cerven zasadita 2
unii-xtx0yxu2hv
C19919
69882-16-2
safranin y
safranin a
basic red 2 [inci]
c.i. basic red 2 [hsdb]
SCHEMBL15265
basic red 2 (safranine o)
3,7-diamino-2,8-dimethyl-5-phenyl-phenazinium chloride
OARRHUQTFTUEOS-UHFFFAOYSA-N
safranine o, c.i. 50240
mfcd00011759
safranine o (c.i. 50240)
safranin o, for microscopy (bact., bot., hist.), indicator (ph 0.3-1.0)
CHEMBL5195997
basic dye (safranine b c.i. 50200)
DTXSID60874047
Q413672
E75934
AS-17149
AMY22413
3,7-dimethyl-10-phenylphenazin-10-ium-2,8-diamine;chloride
A872074
CS-0010127
HY-D0215

Research Excerpts

Overview

Safranine T is a basic compound which mediates electron transfer with illumination.

ExcerptReferenceRelevance
"Safranine T is a basic compound which mediates electron transfer with illumination."( Marked detergents effects on safranine T-mediated photo-induced electron transfer in cytochrome P-450 1A2.
Ito, O; Konami, H; Nakano, R; Sato, H; Shimizu, T, 1995
)
1.3

Toxicity

ExcerptReferenceRelevance
" The verdict of the toxicity assay rendered the treated permeate as biologically safe for discharge or reuse in industrial and domestic purposes."( Optimization and modelling of synthetic azo dye wastewater treatment using Graphene oxide nanoplatelets: Characterization toxicity evaluation and optimization using Artificial Neural Network.
Banerjee, P; Das, P; Mukhopadhayay, A; Sau, S, 2015
)
0.42
" We conclude that the temporary hair dyes may have risk to human health, and those who use them should be aware of their potential toxic effects."( The Bio-Safety Concerns of Three Domestic Temporary Hair Dye Molecules: Fuchsin Basic, Victoria Blue B and Basic Red 2.
Deng, SJ; Jin, SF; Li, HC; Liu, B; Sun, XY; Yan, SQ; Zhao, P, 2019
)
0.51

Compound-Compound Interactions

ExcerptReferenceRelevance
"The aim of this study was to evaluate whether the microfracture combined with osteochondral paste implantation could promote the quality of the regenerated tissue in the knee joints of rabbits."( Microfracture combined with osteochondral paste implantation was more effective than microfracture alone for full-thickness cartilage repair.
Gao, F; Gui, J; Jiang, Y; Lu, Y; Xing, L; Xu, Y, 2013
)
0.39
"Microfracture combined with paste implantation can result in improved quality of the reparative tissue and may have a positive effect on the integration to the surrounding cartilage in the rabbit model."( Microfracture combined with osteochondral paste implantation was more effective than microfracture alone for full-thickness cartilage repair.
Gao, F; Gui, J; Jiang, Y; Lu, Y; Xing, L; Xu, Y, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
"In recent years, mesoporous silica nanoparticles (MSNs) have been used as effective supports for the development of controlled-release nanodevices that are able to act as multifunctional delivery platforms for the encapsulation of therapeutic agents, enhancing their bioavailability and overcoming common issues such as poor water solubility and poor stability of some drugs."( Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells.
Amorós, P; Aznar, E; de la Torre, C; Giménez, C; Gorbe, M; Marcos, MD; Martínez-Máñez, R; Murguía, JR; Sancenón, F, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" The proposed method was successfully applied to the analysis of the cited drugs in dosage forms."( Highly sensitive spectrofluorimetric method for determination of certain aminoglycosides in pharmaceutical formulations and human plasma.
Aly, AA; Hammad, MA; Nagy, DM; Omar, MA, 2013
)
0.39
" Central composite design was used to evaluate the effects and interactions of process parameters including current density, reaction time, initial pH and ES dosage on the BR2 removal efficiency and energy consumption."( Parametric and energy consumption optimization of Basic Red 2 removal by electrocoagulation/egg shell adsorption coupling using response surface methodology in a batch system.
de Carvalho, HP; Dong, L; Huang, J; Liu, G; Liu, X; Yang, X; Zhao, M, 2016
)
0.43
" The decolorization efficiency was improved by optimizing the conditions such as initial pH (3-9), temperature (25-45 °C), initial dye concentration (10-50 mg/L), biosorbent dosage (100-500 mg/L) and contact time (1-6 days)."( Decolorization of safranin using Fissidens species and its ecotoxicological assessments: An in vitro and in silico approach.
Ajarem, JS; Alaguprathana, M; Allam, AA; Kalaiarasi, K; Khim, JS; Kiruthika, T; Poonkothai, M; Selvankumar, T; Sudhakar, C, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
histological dyeA dye used in microscopic or electron microscopic examination of cells and tissues to give contrast and to highlight particular features of interest, such as nuclei and cytoplasm.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic chloride salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (31)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
regulation of gluconeogenesisGlucocorticoid receptorHomo sapiens (human)
chromatin organizationGlucocorticoid receptorHomo sapiens (human)
regulation of DNA-templated transcriptionGlucocorticoid receptorHomo sapiens (human)
apoptotic processGlucocorticoid receptorHomo sapiens (human)
chromosome segregationGlucocorticoid receptorHomo sapiens (human)
signal transductionGlucocorticoid receptorHomo sapiens (human)
glucocorticoid metabolic processGlucocorticoid receptorHomo sapiens (human)
gene expressionGlucocorticoid receptorHomo sapiens (human)
microglia differentiationGlucocorticoid receptorHomo sapiens (human)
adrenal gland developmentGlucocorticoid receptorHomo sapiens (human)
regulation of glucocorticoid biosynthetic processGlucocorticoid receptorHomo sapiens (human)
synaptic transmission, glutamatergicGlucocorticoid receptorHomo sapiens (human)
maternal behaviorGlucocorticoid receptorHomo sapiens (human)
intracellular glucocorticoid receptor signaling pathwayGlucocorticoid receptorHomo sapiens (human)
glucocorticoid mediated signaling pathwayGlucocorticoid receptorHomo sapiens (human)
positive regulation of neuron apoptotic processGlucocorticoid receptorHomo sapiens (human)
negative regulation of DNA-templated transcriptionGlucocorticoid receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
astrocyte differentiationGlucocorticoid receptorHomo sapiens (human)
cell divisionGlucocorticoid receptorHomo sapiens (human)
mammary gland duct morphogenesisGlucocorticoid receptorHomo sapiens (human)
motor behaviorGlucocorticoid receptorHomo sapiens (human)
cellular response to steroid hormone stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to glucocorticoid stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to dexamethasone stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to transforming growth factor beta stimulusGlucocorticoid receptorHomo sapiens (human)
neuroinflammatory responseGlucocorticoid receptorHomo sapiens (human)
positive regulation of miRNA transcriptionGlucocorticoid receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayGlucocorticoid receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (20)

Processvia Protein(s)Taxonomy
RNA polymerase II transcription regulatory region sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
core promoter sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription factor activityGlucocorticoid receptorHomo sapiens (human)
RNA bindingGlucocorticoid receptorHomo sapiens (human)
nuclear receptor activityGlucocorticoid receptorHomo sapiens (human)
nuclear glucocorticoid receptor activityGlucocorticoid receptorHomo sapiens (human)
steroid bindingGlucocorticoid receptorHomo sapiens (human)
protein bindingGlucocorticoid receptorHomo sapiens (human)
zinc ion bindingGlucocorticoid receptorHomo sapiens (human)
TBP-class protein bindingGlucocorticoid receptorHomo sapiens (human)
protein kinase bindingGlucocorticoid receptorHomo sapiens (human)
identical protein bindingGlucocorticoid receptorHomo sapiens (human)
Hsp90 protein bindingGlucocorticoid receptorHomo sapiens (human)
steroid hormone bindingGlucocorticoid receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingGlucocorticoid receptorHomo sapiens (human)
estrogen response element bindingGlucocorticoid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
nucleusGlucocorticoid receptorHomo sapiens (human)
nucleusGlucocorticoid receptorHomo sapiens (human)
nucleoplasmGlucocorticoid receptorHomo sapiens (human)
cytoplasmGlucocorticoid receptorHomo sapiens (human)
mitochondrial matrixGlucocorticoid receptorHomo sapiens (human)
centrosomeGlucocorticoid receptorHomo sapiens (human)
spindleGlucocorticoid receptorHomo sapiens (human)
cytosolGlucocorticoid receptorHomo sapiens (human)
membraneGlucocorticoid receptorHomo sapiens (human)
nuclear speckGlucocorticoid receptorHomo sapiens (human)
synapseGlucocorticoid receptorHomo sapiens (human)
chromatinGlucocorticoid receptorHomo sapiens (human)
protein-containing complexGlucocorticoid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1893988Binding affinity to human GR assessed as inhibition of enzyme substrate complex formation2021European journal of medicinal chemistry, Jan-15, Volume: 210Xanthenes in Medicinal Chemistry - Synthetic strategies and biological activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (406)

TimeframeStudies, This Drug (%)All Drugs %
pre-199076 (18.72)18.7374
1990's74 (18.23)18.2507
2000's101 (24.88)29.6817
2010's130 (32.02)24.3611
2020's25 (6.16)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 65.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index65.78 (24.57)
Research Supply Index6.06 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index111.48 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (65.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.47%)5.53%
Reviews2 (0.47%)6.00%
Case Studies2 (0.47%)4.05%
Observational0 (0.00%)0.25%
Other418 (98.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]